세계의 신경혈관 디바이스 시장 규모는 2024년에 30억 달러에 달했습니다. IMARC Group은 향후 이 시장이 2033년까지 47억 달러에 달할 전망이며, 2025-2033년 4.9%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측하고 있습니다. 현재 시장을 독점하고 있는 것은 북미로, 2024년의 시장 점유율은 27.8%이었습니다. 북미 지역 성장의 원동력은 선진적인 헬스케어 인프라, 혁신적인 신경혈관 디바이스의 보급, 신경혈관 장애 증례 증가, 연구 이니셔티브에 대한 강력한 지원입니다.
현재 대중들 사이에서 뇌졸중, 동맥류, 동정맥 기형 등의 질병 발생률이 상승하고 있는 것이 시장 성장을 가속하는 주요 요인 중 하나가 되고 있습니다. 이러한 질환에는 정확한 치료가 필요하며, 현대의 신경혈관 디바이스는 이에 대처하도록 조정되어 있어 환자의 생존율과 전체적인 삶의 질을 높이고 있습니다. 게다가 신경혈관의 문제를 떠안기 쉬운 고령자 증가가, 고령자 특유의 헬스케어 요건에 맞춘 강화된 치료 솔루션의 수요를 촉진하고 있습니다. 게다가 플로우 다이버터, 혈전 제거 장치, 색전 코일과 같은 저침습 기술의 진보는 수기 결과를 향상시키고 있습니다. 이러한 장치는 위험을 줄이고 회복 기간을 단축하며 맞춤형 솔루션을 제공함으로써 세계 헬스케어 환경에서의 광범위한 사용을 촉진하고 있습니다. 게다가 많은 국가에서 상환제도가 강화되면서 환자들은 고가의 신경혈관 치료를 받을 수 있게 되었고, 신경혈관 디바이스는 보다 저렴한 가격으로 이용하기 쉬워지고 있습니다.
미국은 치료의 정확성과 안전성을 높이기 위해 특별히 설계된 혁신적인 신경혈관 디바이스의 도입에 지원되는 주요 시장입니다. 시인성과 배치 정확도를 높이는 코일 어시스트 스텐트 등 최첨단 기술의 존재는 복잡한 신경혈관 문제를 효과적으로 치료하는 데 점점 더 중점을 두고 있음을 보여줍니다. 이러한 진보는, 임상 요건에 맞추어 맞춤형 혁신적 솔루션의 제공에 대한 톱 제조업체의 헌신을 강조하고 있습니다. 예를 들어 2024년 MicroVention은 광경부 두개내 동맥류 치료를 목적으로 한 LVIS EVO Intraluminal Support Device의 미국 상업적 출시를 선언했습니다. 이는 미국 최초의 완전히 가시화된 코일 어시스트 두개 내 스텐트로, 가시화와 정확한 위치 결정이 개선되고 있습니다. 이 출시는 신경혈관 치료 기술의 진보에 대한 마이크로벤션의 약속을 강조하는 것입니다. 게다가 뇌졸중의 예방, 신속한 진단, 치료의 선택에 관한 계몽 프로그램의 증가는 신속한 의료 개입으로 이어지고 있습니다. 전문가 개발 프로그램도 헬스케어 종사자의 능력을 높이고 선진적 기술 사용을 독려하고 있습니다.
기술 혁신이 혁신을 촉진
세계의 신경혈관 디바이스의 부문에서는 기술 혁신의 진행이 중요한 요소가 되고 있습니다. 의료기기의 진보는 신경혈관의 처치를 일변시켜, 다양한 신경혈관 문제에 대한 새로운 치료 선택지를 제공하고 있습니다. Institute for Health Metrics and Evaluation의 보고에 따르면 2021년에 질병, 장애, 조기 사망으로 상실되는 건강 수명은 신경 질환으로 4억 4,300만 년에 달했다고 합니다. 3D 프린팅, 선진 화상 기술, 저침습 접근법 등의 최첨단 기술은 환자 케어에 혁명을 가져오고 있습니다. 이러한 개발을 통해 보다 정확한 진단 및 치료가 가능해져 환자의 회귀가 향상되고 위험이 줄어듭니다. 게다가 신경혈관 인터벤션에서 로봇 공학 및 인공 지능(AI)의 통합은, 손기술을 대폭 개선해, 개별화된 치료를 제공하고 있습니다. 지속적인 연구개발(R&D)로 기술 진보의 끊임없는 추구가 신경혈관 디바이스 시장을 견인하고 있습니다.
신경혈관 장애의 유병률 상승
세계 신경혈관 디바이스 시장의 상승 궤도는 신경혈관 장애의 유병률 상승과 본질적으로 관련되어 있습니다. 보고에 따르면 2021년에는 전 세계적으로 30억 명 이상이 신경 장애의 영향을 받고 있습니다. 세계적인 건강 문제는 뇌졸중, 동맥류, 동정맥 기형 등의 질환에 의해 현저하게 초래됩니다. 고령자는 라이프 스타일의 변화 및 위험 요소와 함께 이러한 질환의 발생 증가로 이어지고 있습니다. 이러한 증례의 증가에는 정확한 진단, 치료, 치료 후 모니터링을 위한 효율적이고 최신의 신경혈관 디바이스 개발이 필요합니다. 환자의 불쾌감을 줄이고 회복 기간을 단축하기 위해 저침습 수기의 수요가 현저히 증가하고 있습니다. 그 결과, 시장은 독창적인 제품과 솔루션으로 이러한 수요 증가에 대응해, 환자의 치료 결과와 전체적인 삶의 질을 높이는 중요한 요인으로서의 역할을 강화하고 있습니다.
노인 및 저침습 치료에 대한 접근성
노인은 세계 신경혈관 디바이스 시장 확대의 중요한 촉진요인이 되고 있습니다. 인구조사국에 따르면 2020년 노인은 5,580만 명에 이르렀으며 미국 인구 전체의 16.8%를 차지했습니다. 노인이 신경혈관 질환에 쉽게 이환됨에 따라 포괄적이고 저침습적인 치료 옵션에 대한 수요가 높아지고 있습니다. 노인은 보통 신체적 스트레스 및 회복 시간을 줄이는 저침습 수기를 선호합니다. 그 결과, 생산자는 이 환자 그룹에 맞춘 기기의 개발에 주력해, 안전성 및 효율성을 확보하고 있습니다. 저침습 치료가 가능해짐으로써 환자의 컴플라이언스가 향상되어 헬스케어 산업에서는 효과적이고 경제적인 선택지가 계속 중시되고 있습니다. 고령화 사회의 요구와 시장에서 입수 가능한 제품과의 관련은, 진화하는 헬스케어 수요에 대응하기 위한 신경혈관 디바이스 부문의 중요한 역할을 부각시키고 있습니다.
The global neurovascular devices market size was valued at USD 3.0 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.7 Billion by 2033, exhibiting a CAGR of 4.9% from 2025-2033. North America currently dominates the market, holding a market share of 27.8% in 2024. The growth of the North American region is driven by advanced healthcare infrastructure, widespread adoption of innovative neurovascular devices, increasing cases of neurovascular disorders, and strong support for research initiatives.
At present, the rising incidence of conditions, such as strokes, aneurysms, and arteriovenous malformations, among the masses represent one of the major factors impelling the market growth. These conditions necessitate exact treatment, which contemporary neurovascular instruments are tailored to tackle, enhancing patient survival rates and overall quality of life. Moreover, the increasing elderly population, which is more prone to neurovascular issues, is driving the demand for enhanced treatment solutions tailored to their unique healthcare requirements. Additionally, advancements in less invasive technologies, like flow diverters, thrombectomy devices, and embolization coils, are enhancing procedural results. These devices lower risks, shorten recovery durations, and provide customized solutions, promoting extensive use in healthcare settings globally. Furthermore, enhanced reimbursement systems in numerous countries allow patients to obtain expensive neurovascular therapies, rendering neurovascular devices more affordable and accessible.
The United States represents a major market, supported by the introduction of innovative neurovascular devices specifically designed to enhance treatment precision and safety. The presence of cutting-edge technologies, such as coil-assist stents, which enhance visibility and placement precision, indicates an increasing emphasis on effectively treating intricate neurovascular issues. These advancements emphasize the dedication of top manufacturers to providing innovative solutions customized for clinical requirements. For instance, in 2024, MicroVention declared the commercial release of the LVIS EVO Intraluminal Support Device in the United States, intended for the treatment of wide-neck intracranial aneurysms. It is the initial entirely visible coil-assist intracranial stent in the US, providing improved visualization and accurate positioning. This launch underscores MicroVention's commitment to advancing neurovascular treatment technologies. Furthermore, the growing number of awareness programs about stroke prevention, rapid diagnosis, and treatment choices is leading to quicker medical intervention. Professional development programs are also enhancing the abilities of healthcare workers, encouraging the use of sophisticated technology.
Technological advancements driving innovation
In the field of global neurovascular devices, a vital factor is the ongoing rise in technological innovations. Advancements in medical devices have transformed neurovascular procedures, offering novel treatment options for a range of neurovascular problems. The Institute for Health Metrics and Evaluation reports that neurological disorders accounted for 443 million years of healthy life lost from illness, disability, and early death in 2021. Cutting-edge technologies such as 3D printing, advanced imaging techniques, and minimally invasive approaches are revolutionizing patient care. These developments enable more precise diagnosis and treatment, enhancing patient outcomes and reducing risks. Moreover, the integration of robotics and artificial intelligence (AI) in neurovascular interventions is greatly improving procedures and offering personalized therapies. With ongoing research and development (R&D), the relentless pursuit of technological progress drives the neurovascular devices market.
Rising prevalence of neurovascular disorders
The upward trajectory of the global neurovascular devices market is intrinsically linked to the rising prevalence of neurovascular disorders. Reports indicate that in 2021, over 3 billion individuals around the globe were affected by a neurological disorder. Health challenges on a global scale are significantly posed by conditions like strokes, aneurysms, and arteriovenous malformations. The elderly population, along with shifting lifestyles and risk elements, has led to an increased occurrence of these conditions. This increase in cases requires the creation of efficient and modern neurovascular instruments for precise diagnosis, therapy, and monitoring after treatment. The demand for minimally invasive procedures has notably increased because of their lowered patient discomfort and faster recovery periods. As a result, the market addresses this increasing demand with creative products and solutions, reinforcing its role as a crucial factor in enhancing patient results and overall quality of life.
Geriatric population and accessibility to minimally invasive treatments
The geriatric demographic stands as a significant driver in the expansion of the global neurovascular devices market. According to the Census Bureau, in 2020, the senior population reached 55.8 million, representing 16.8% of the overall US populace. With the growing susceptibility of the elderly population to neurovascular diseases, the demand for comprehensive and minimally invasive treatment options increases. Older individuals usually prefer minimally invasive procedures that lessen physical stress and recovery time. As a result, producers focus on developing devices tailored for this patient group, ensuring their safety and efficiency. The availability of minimally invasive treatments improves patient compliance and addresses the ongoing emphasis in the healthcare industry on effective and economical options. The link between the needs of the aging population and the market's available products highlights the crucial role of the neurovascular devices sector in meeting evolving healthcare demands.
Cerebral and aneurysm coiling devices (embolic coils, flow diverters, and liquid embolic agents) lead the market with 37.8% of market share in 2024. Cerebral embolization and aneurysm coiling devices dominate the market due to their demonstrated efficacy in treating critical conditions like aneurysms and arteriovenous malformations. Such devices, like embolic coils, flow diverters, and liquid embolic agents, provide less invasive treatment alternatives that greatly decrease recovery durations and procedural hazards. Their accuracy in detecting aneurysms and averting rupture has rendered them essential in neurovascular procedures. Ongoing technological progress has improved their effectiveness, allowing customized solutions for various patient requirements. These devices are commonly used in modern healthcare centers, bolstered by the increasing recognition of their advantages among healthcare practitioners. Cerebral embolization and aneurysm coiling devices have become essential in this market segment due to their vital role in tackling the rising incidence of neurovascular disorders, fostering innovation and enhancing patient outcomes.
Ischemic stroke is a significant segment in the market, driven by the rising global incidence of strokes. These instruments, such as thrombectomy devices and stents, are essential in restoring blood circulation and reducing brain injury during crises. The rise in their adoption is driven by progress in less invasive techniques and a heightened focus on early intervention, leading to better patient results.
Aneurysm is a significant issue, as untreated cerebral aneurysms can lead to death. Devices like embolic coils and flow diverters play a vital role in isolating aneurysms, preventing rupture, and reducing complications. Continuous improvements in device design and a rising application in advanced medical settings are enhancing this segment's importance in successfully addressing complex neurovascular challenges.
Arteriovenous malformation and fistulas (AVM) benefits from specialized neurovascular devices that safely and efficiently manage abnormal blood vessel connections. Liquid embolics and other embolization devices are widely used to reduce bleeding risks and enhance treatment success rates. Increasing awareness about AVM conditions and advancements in imaging technologies further drive the adoption of these devices.
Stenosis is vital segment in the market driven by the increasing demand for treatments for constricted blood vessels in the brain. Stenting systems and balloon angioplasty tools are essential for restoring adequate blood circulation, lowering the likelihood of stroke, and enhancing long-term vascular wellness. The segment is experiencing expansion because of the rising occurrence of atherosclerosis and associated ailments.
Others encompass various neurovascular conditions requiring specialized interventions. This category includes devices designed for rare or complex disorders, such as dural fistulas or Moyamoya disease. The ongoing development of targeted solutions and the expansion of clinical applications highlight the importance of this segment in addressing diverse patient needs.
Hospitals lead the market, holding a 70.9% share in 2024. Hospitals hold the largest market share attributed to their advanced infrastructure and ability to handle complex neurovascular procedures. They offer access to multidisciplinary teams of specialists, ensuring comprehensive care for patients with stroke, aneurysms, and other neurovascular disorders. The availability of state-of-the-art equipment and facilities for diagnosis and minimally invasive treatments enhances the success rate of procedures performed in hospitals. High patient inflow, combined with round-the-clock emergency services, positions hospitals as the primary choice for neurovascular treatments. Their emphasis on clinical training and adoption of innovative technologies ensures the integration of the latest devices and techniques into practice. Hospitals' capability to effectively handle both acute and chronic neurovascular cases makes them crucial in promoting the use of neurovascular devices.
In 2024, North America held the biggest market share at 27.8%. North America leads the market because of its sophisticated healthcare infrastructure and the extensive access to state-of-the-art medical technologies. The area enjoys a significant number of well-equipped medical centers and a vast array of proficient healthcare experts specializing in neurovascular procedures. Continual research and development efforts, backed by strong government and private sector investment, have hastened the launch of innovative devices designed for intricate neurological disorders. The increasing recognition of neurovascular conditions and the significance of prompt treatment further propel the uptake of these devices. Moreover, North America possesses a robust regulatory system that promotes prompt product approvals, guaranteeing the accessibility of safe and efficient treatment alternatives. The presence of key market players in the region enhances accessibility to a wide range of neurovascular devices, fostering continuous advancements. In 2024, Cerenovus, part of Johnson & Johnson MedTech, launched the Cereglide 71 catheter for acute ischemic stroke revascularization in the U.S. Featuring TruCourse technology, it offers improved navigation, trackability, and compatibility for thrombectomy procedures. This innovation enhances Cerenovus' Stroke Solutions portfolio, addressing critical clinical needs in stroke care.
United States Neurovascular Devices Market Analysis
The United States represented 70.10% of the overall market share in North America. The market for neurovascular devices in the United States is presently propelled by innovations in minimally invasive surgical methods, allowing quicker recovery periods and fewer complications for patients receiving care for neurovascular issues. Firms are proactively putting resources into creating advanced devices, like stent retrievers and flow diverters, which are showing enhanced effectiveness in treating ischemic and hemorrhagic strokes. The market is also experiencing a rise in the use of AI-driven imaging technologies and robotic-assisted treatments, which are improving accuracy and clinical results in neurovascular procedures. Increasing awareness initiatives are informing healthcare professionals and patients about the early detection and management of neurovascular conditions, thus broadening the base of patients pursuing these advanced options. Hospitals and surgical facilities are emphasizing the integration of advanced neurovascular device technologies to enhance procedural efficiency and meet the increasing patient demand. Moreover, insurance companies are increasing coverage for cutting-edge procedures, thus making advanced neurovascular treatments more available to a wider audience. According to the U.S. Department of Agriculture (USDA), the United States population hit 334,914,895 in 2023. The FDA is promoting a competitive environment that stimulates innovation by expediting the authorization and approval of novel neurovascular devices. Medical facilities are also improving their training programs for physicians to improve their proficiency with these complex gadgets, which will expand their market reach.
Europe Neurovascular Devices Market Analysis
The market for neurovascular devices in Europe is presently expanding due to a combination of factors. The area is experiencing a rise in the use of sophisticated minimally invasive techniques for addressing neurovascular conditions like aneurysms, ischemic strokes, and arteriovenous malformations, as medical professionals aim to shorten recovery periods and enhance patient results. Governments and private entities are vigorously financing research and clinical studies for cutting-edge devices such as flow diverters and embolization coils, which is hastening product development and market introduction. At the same time, the increasing elderly population in Europe is leading to a higher incidence of neurovascular diseases, encouraging healthcare systems to enhance their neurointerventional services. As reported by Eurostat, in 2019, there were 90.4 million elderly individuals (aged 65 and above) residing in the EU-27. Hospitals and specialized clinics are consistently enhancing their equipment collections to feature advanced imaging and navigation technologies that support neurovascular devices, improving procedural precision. Moreover, European regulatory authorities are simplifying approval procedures for novel neurovascular devices, promoting quicker market entry of innovative solutions. As emphasis on international collaborations increases, manufacturers are establishing strategic alliances with research institutes and hospitals, promoting innovation that meets local requirements. Additionally, the growing accessibility of training programs for neurointerventional specialists is enhancing procedural skills, facilitating the use of neurovascular devices in everyday clinical practice throughout Europe.
Asia Pacific Neurovascular Devices Market Analysis
The neurovascular devices market in the Asia-Pacific region is presently experiencing growth fueled by various localized factors. Improvements in healthcare systems in developing nations such as India and Indonesia are facilitating improved access to neurovascular treatments, bolstered by government efforts to increase the accessibility of sophisticated medical equipment. The area is experiencing a rise in neurovascular disorders like strokes and aneurysms, linked to lifestyle changes, an aging population, and a higher occurrence of hypertension and diabetes. As per the IDF Diabetes Atlas, the number of individuals impacted by diabetes (in thousands) in China in 2021 is 140,869.6. Healthcare providers are progressively embracing minimally invasive techniques because of their reduced risk factors and quicker recovery periods, driving the need for sophisticated neurovascular tools such as embolic coils and flow diverters. Top manufacturers are partnering with local distributors and establishing strategic alliances to broaden their presence, particularly in markets such as China and Japan, where rapid adoption of advanced devices is driven by an increasing emphasis on state-of-the-art medical technologies. At the same time, the growth of medical tourism in nations like Thailand and Malaysia is enhancing access to cost-effective and high-quality neurovascular treatments, drawing in patients from around the world. Regulatory authorities in the area are simplifying approval procedures, enabling quicker market access for advanced neurovascular products, thus fostering innovation and rivalry in the Asia-Pacific market.
Latin America Neurovascular Devices Market Analysis
The neurovascular devices market in Latin America is supported by the growing acceptance of minimally invasive surgical methods and increased awareness among patients and healthcare providers about their benefits, including quicker recovery times and lower complication risks. Hospitals and specialized clinics are upgrading their infrastructure and resources, focusing on equipping facilities with advanced neurovascular equipment to meet the increasing demand for stroke care and other neurovascular disorders. The region is seeing a rise in healthcare investment, especially in countries like Brazil and Mexico, where officials are concentrating on enhancing neurology services through collaborations between public and private sectors. Additionally, companies are actively launching creative products tailored to the specific needs of Latin American communities, addressing issues such as affordability and accessibility. The growing prevalence of lifestyle-associated risk factors, such as hypertension and diabetes, is contributing to a greater number of strokes, consequently increasing reliance on advanced technologies for clot removal and aneurysm management. As per the IDF Diabetes Atlas, the diabetes prevalence in Mexico was approximately 17% in 2021. At the same time, healthcare professionals regularly participate in specialized training sessions provided by device manufacturers to guarantee the effective use of these technologies. Community programs that encourage early detection and treatment offer extra assistance to the market, leading to improved patient results.
Middle East and Africa Neurovascular Devices Market Analysis
The neurovascular device market in the Middle East and Africa is growing due to multiple region-specific factors. To address the growing prevalence of neurovascular diseases including aneurysms and strokes, governments and commercial healthcare organizations are now investing more in healthcare infrastructure, especially in institutions devoted to neurology. Medical tourism is expanding in countries like the UAE and South Africa, supported by advanced neurological treatment facilities that are encouraging the utilization of minimally invasive neurovascular devices. According to the Ministry of Economy, the medical tourism industry in the UAE generated AED 12.1 Billion (USD 3.29 Billion) in 2018. Concurrently, regional healthcare entities are strengthening partnerships with international producers to launch advanced technological devices in the market, addressing the unmet needs in stroke management and interventional neurology. Furthermore, the rising prevalence of hypertension, diabetes, and sedentary habits is elevating the demand for new approaches to tackle associated neurovascular problems. Training sessions and workshops are being conducted more frequently to improve the abilities of healthcare professionals in using advanced equipment, thereby guaranteeing improved patient results. Governments are swiftly accelerating regulatory clearances and endorsing clinical trials in this field, enhancing access to groundbreaking neurovascular products. These elements are jointly establishing a conducive atmosphere for the continuous expansion of the neurovascular devices market in the region.
Key players in the market are focusing on expanding their product portfolios through innovative solutions and advanced technologies to address complex neurovascular conditions. They are heavily investing in research operations to enhance device efficiency, safety, and minimally invasive capabilities. Strategic collaborations, mergers, and acquisitions are being pursued to strengthen market presence and gain access to emerging regions. These companies are also prioritizing regulatory approvals to ensure global availability and compliance with healthcare standards. Additionally, they are leveraging advanced manufacturing techniques to reduce production costs while maintaining quality. In 2024, Philips and Medtronic Neurovascular announced a joint advocacy initiative designed to enhance global access to essential stroke therapies. The collaboration seeks to raise awareness, improve access to treatments, and implement advanced technologies for effective stroke care management. The two firms joined the World Stroke Organization Advocacy Coalition to advocate for global stroke care policies.